![](/img/cover-not-exists.png)
PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN FIRST-LINE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FIT ELDERLY PATIENTS: AN ECONOMICAL ANALYSIS OF A PROSPECTIVE PHASE 2 STUDY (GFPC 0504)
C Chouaid, H Lecaer, J Crequit, I Monnet, S Chouabe, C Locher, D Paillotin, JB Auliac, P Thomas, A VergnenegreVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71979-9
File:
PDF, 79 KB
english, 2010